Update And New Findings From The Resilient Trial Comparing The Life Stent With Poba: Improvement With Stenting Is Durable Beyond One Year

Main Category: Cardiovascular / Cardiology
Also Included In: Medical Devices / Diagnostics
Article Date: 24 Nov 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


The RESILIENT TRIAL is a landmark prospective randomized trial comparing two strategies of revascularization for superficial femoral artery stenosis and occlusions.

The trial compared percutaneous transluminal angioplasty (PTA) versus angioplasty and stenting from both an acute and 12 month outcome point of view. In the initial evaluation, there was a statistically significant benefit for use of the self-expanding nitinol LifeStent compared to angioplasty alone, and this benefit seemed to continue through to the one year time period.

Dr. Barry Katzen, Professor of Radiology at the University of South Florida College of Medicine and Founder and Medical Director of the Baptist Cardiac and Vascular Institute in Miami, Florida, presented additional data at the 24-month point.

With all patients (data still being collected from some sites) having reached their 24- month follow-up and with freedom from target lesion revascularization maintained in the test group, the data continues to support the use of stenting in most superficial femoral artery lesions, while angioplasty may be effective in certain other lesions, particularly in those that are shorter in length and less complex.

VEITH SYMPOSIUM - New York, November 19th to 23rd

Now in its fourth decade, VEITH SYMPOSIUM provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.

VEITHsymposium is sponsored by Cleveland Clinic, Cleveland, OH.

www.veithsymposium.org

Source
Pauline T. Mayer
www.ptmhcm.com

Article adapted by Medical News Today from original press release.
Visit our cardiovascular / cardiology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Pauline Mayer. "Update And New Findings From The Resilient Trial Comparing The Life Stent With Poba: Improvement With Stenting Is Durable Beyond One Year." Medical News Today. MediLexicon, Intl., 24 Nov. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/130504.php>

APA
Pauline Mayer. (2008, November 24). "Update And New Findings From The Resilient Trial Comparing The Life Stent With Poba: Improvement With Stenting Is Durable Beyond One Year." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/130504.php.

Please note: If no author information is provided, the source is cited instead.




Cardiovascular / Cardiology

What Is Heart Rate?

A person's heart rate, also known as their pulse, refers to how many times their heart beats per minute. Our heart rates vary tremendously, depending on the demands we make on our bodies. Read more...

Most Popular Articles



Follow Our Cardiovascular News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cardiovascular / Cardiology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »